MSF: Catastrophic health crisis in Sudan demands more action
News Sep 21, 2023
Get the latest news, stories, videos, and more from our medical humanitarian projects around the world.
News Sep 21, 2023
Speaking out about the emergencies our staff and patients witness is part of who we are. Explore our history and principles.
News | Sep 22, 2023
News | Sep 19, 2023
Cepheid and its parent company Danaher announced today that they are reducing the price of the Xpert MTB/RIF test for TB by 20 percent in high-TB-burden countries.
Read MoreStory | Sep 18, 2023
Christophe Perrin, the MSF Access Campaign‘s TB advocacy pharmacist, discusses the need for secure affordable access to improved TB medicines.
Read MoreNews | Sep 12, 2023
TB is curable but remains the world’s leading infectious disease killer as pharma corporations stand in the way of affordable medical tools
Read MoreNews | Jul 18, 2023
Recent deal offering controlled generics access in limited countries does not go far enough
Read MoreStory | Jul 13, 2023
J&J must end its patent monopoly on bedaquiline so generic versions of this lifesaving drug can be widely produced.
Read MoreNews | May 26, 2023
Governments must now implement the resolution and make sure diagnostic tools are widely affordable and accessible
Read MoreStory | May 15, 2023
Your unrestricted gifts enable us to provide lifesaving medical humanitarian care on the ground and speak out about what we see.